Schwabe Pharmaceuticals Acquires MH Pharma, UK

Schwabe Pharmaceuticals Acquires MH Pharma, UK

KARLSRUHE, Germany -- Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany, today announced the acquisition of MH Pharma (UK) Ltd., Marlow, UK. Schwabe Pharmaceuticals, a family owned company founded in 1866, is known as one of the world’s leading companies in the development, manufacturing and marketing of phytomedicines. With the acquisition of the privately held MH Pharma in UK, Schwabe will gain access to the UK market. Schwabe has more than 20 subsidiaries and joint ventures in European countries as well as in the US, Mexico and China. Worldwide sales reached 500 mio € in 2007.

Suggested Articles

More than half of the participants met the primary endpoint, teeing Sanofi up to file for FDA approval of the complement C1s inhibitor.

Cellarity is combining artificial intelligence, a protein discovery platform and what it calls “network biology” in a new drug discovery approach.

Bluebird bio offered the first glimpse of how its CAR-T follow-up is working in multiple myeloma patients who have tried several other treatments.